Leading company in the world of biogas technology, Sistema.bio, says it has raised $15 million in funding to support its international expansion. In the previous three years, the company's revenues have increased by more than five times, largely due to the profound effects that the global climate, economy, and health of farmers have had. The latest funding will help it maintain the expansion of its alliances, markets it serves, and the variety of bioenergy products it offers farmers.

The financing, which was fully provided by Sistema.bio's current investors and was led by ElectriFI and managed by the EDFI Management Company, would support a number of growth and diversification objectives prior to Sistema.bio's projected Series C financing in 2025. The funding was largely contributed to by Sistema.bio's current equity investors, which included Blink CV, EcoEnterprises Fund, AXA IM Alts, Chroma Impact Investment, and KawiSafi Ventures. Existing lenders FMO, Triodos, and EcoEnterprises contributed more funding to expand the facilities already in place. The catalytic junior loan was given by BIX Capital and the UK charity Shell Foundation, and it was partially financed by UK government help.

Speaking to this, Alexander Eaton, CEO and co-founder of Sistema.bio, “The continued trust of ElectriFI and our coalition of investors allows us to focus on our work of engaging millions of farmers to help fight the climate crisis and deliver food security. We are now better positioned to reach our goal of empowering one million farmers by 2025 and reducing 1% of global emissions by 2030.”

Similarly, Manoel Ancion, Managing Director at Chroma Impact Investment, “Chroma Impact is excited to deepen our collaboration with Sistema.bio as they continue to lead the way in sustainable energy solutions for smallholder farmers”. By aligning with Sistema.bio, we are investing in a future where agriculture plays a key role in the global fight against climate change and poverty.

Joyce Chacho, Independent Board Chair at Sistema.bio says, “This strategic investment underscores the confidence of Sistema.bio’s investors in the company’s mission to scale up its transformative impact across Asia, Africa and Latin America”.